<DOC>
	<DOCNO>NCT00861835</DOCNO>
	<brief_summary>Purpose : Previous study suggest increase diagnostic yield bronchoscopic ( FB ) transbronchial needle aspirate ( TBNA ) specimens mediastinal lymph node use rapid on-site evaluation cytopathology ( ROSE ) limit lack randomization . The investigator perform first randomized-prospective trial comparing ROSE ( R ) on-site cytopathology assessment ( NR ) . Methods : All patient refer eligible . 78 patient randomize R NR group . For R procedure , specimen defer result available on-site cytopathologist . Diagnoses make procedure record . The primary end-points specimen adequacy diagnostic yield .</brief_summary>
	<brief_title>Trial Rapid On-Site Evaluation Transbronchial Needle Aspirate ( TBNA )</brief_title>
	<detailed_description />
	<criteria>Eligible patient include adult refer bronchoscopy anticipate TBNA . Patients exclude attend physician felt ROSE must use diagnosis patient refuse consent .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
</DOC>